Showing results (1401-1410 of 1,504) with videos related to
Sort By:
Pageof 151
Familial Cancer|June 22, 2021
A patient with very early onset FH-deficient renal cell carcinoma diagnosed at age sevenRieko Taniguchi, Hideki Muramatsu, Yusuke Okuno, et al.Familial Cancer|June 25, 2021
Surveillance recommendations for DICER1 pathogenic variant carriers: a report from the SIOPE Host Genome Working Group and CanGene-CanVar Clinical Guideline Working GroupJette J Bakhuizen, Helen Hanson, Karin van der Tuin, et al.Familial Cancer|December 13, 2022
Two unique BAP1 pathogenic variants identified in the same family by panel cascade testingLindsey Byrne, Cana Ingalls, Aliya Ansari, et al.Familial Cancer|September 12, 2020
Prevalence of pancreaticobiliary cancers in Irish families with pathogenic BRCA1 and BRCA2 variantsRobert Power, Cristin Leavy, Carmel Nolan, et al.Familial Cancer|July 7, 2021
Patient ethnicity and cascade genetic testing: a descriptive study of a publicly funded hereditary cancer programEryn F Braley, Angela C Bedard, Jennifer Nuk, et al.Familial Cancer|October 14, 2020
The role of TP53 pathogenic variants in early-onset HER2-positive breast cancerCarla Escudeiro, Carla Pinto, Joana Vieira, et al.Familial Cancer|June 17, 2022
Mainstreaming germline genetic testing for patients with pancreatic cancer increases uptakeMitchell L Ramsey, Jewel Tomlinson, Rachel Pearlman, et al.Familial Cancer|July 8, 2022
Prevalence of FANCM germline variants in BRCA1/2 negative breast and/or ovarian cancer patients from PakistanMuhammad Usman Rashid, Noor Muhammad, Umara Shehzad, et al.Familial Cancer|May 15, 2022
Healthcare professionals' perspectives on implementation of universal tumor DNA testing in ovarian cancer patients: multidisciplinary focus groupsVera M Witjes, Jozé C C Braspenning, Nicoline Hoogerbrugge, et al.Familial Cancer|May 15, 2022
Long-term chemoprevention in patients with adenomatous polyposis coli: an observational studyTeresa M Neuhann, Katharina Haub, Verena Steinke-Lange, et al.Pageof 151